Use Able AI chat for product recommendations

Recombinant Rat gp130/IL6ST protein (hFc Tag)

Species

Rat

Purity

>90 %, SDS-PAGE

Tag

hFc Tag

Activity

not tested

Cat no : Eg0843



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Rat gp130 protein Gln23-Glu618 (Accession# NP_001008725.2) with a human IgG1 Fc tag at the C-terminus.
GeneID 25205
Accession NP_001008725.2
PredictedSize 93.7 kDa
SDS-PAGE 100-130 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

Glycoprotein 130 (gp130, also known as IL6ST, CD130 or IL6-beta) is a ubiquitously expressed, signal-transducing receptor that serves as the signal transduction unit for IL-6 family of cytokines, including IL-6, IL-11, IL-27, leukemia inhibitory factor (LIF), OSM, ciliary neurotrophic factor (CNTF), cardiotrophin 1 (CT-1), and cardiotrophin-like cytokine (CLC). These cytokines signal through the gp130/Jak/STAT pathway. Binding of IL-6 to IL-6R induces gp130 homodimerization and formation of a high-affinity receptor complex, which activates Jaks. That causes phosphorylation of gp130 tyrosine residues which in turn activates STAT3. gp130 is a type I transmembrane protein, and can also exist as a soluble form (sgp130). sgp130 binds to sIL-6R/IL-6 complexes and prevents their interactions with membrane-anchored gp130 on target cells.

References:

1. T Taga, et al. (1997) Review Annu Rev Immunol. 15:797-819. 2. F A Montero-Julian, et al. (1997) Clin Cancer Res. 3(8):1443-51. 3. P C Heinrich, et al. (1998) Biochem J.334 ( Pt 2)(Pt 2):297-314. 4. J S Silver, et al. (2010) Review J Leukoc Biol. 88(6):1145-56.

||
New chat

Able™

正在加载,请稍候...